Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8881 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8806 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8623 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8623 |
High Similarity |
NPD1613 |
Approved |
0.8613 |
High Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8467 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8273 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8273 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.8088 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7935 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7926 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7842 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7834 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7821 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7815 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7791 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7712 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7643 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7613 |
Intermediate Similarity |
NPD1653 |
Approved |
0.761 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7607 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7586 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7574 |
Intermediate Similarity |
NPD6671 |
Approved |
0.755 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7531 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7434 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7419 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7419 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7413 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7412 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7412 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7407 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7388 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7388 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7386 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7375 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7362 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7355 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7355 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7349 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7343 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7343 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7343 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7324 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7317 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7299 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7296 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7294 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7292 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7289 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7279 |
Intermediate Similarity |
NPD228 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7261 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7248 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7237 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7237 |
Intermediate Similarity |
NPD6100 |
Approved |
0.723 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7205 |
Intermediate Similarity |
NPD37 |
Approved |
0.7203 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7202 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7202 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.72 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7193 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7192 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7178 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7178 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7169 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7169 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7164 |
Intermediate Similarity |
NPD968 |
Approved |
0.7162 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7161 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7143 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7133 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7133 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7118 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7117 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7105 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7105 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7103 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7078 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7076 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7067 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7063 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7063 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7059 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7059 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7055 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7051 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7051 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.705 |
Intermediate Similarity |
NPD1398 |
Phase 1 |
0.7045 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7035 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7035 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7032 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7032 |
Intermediate Similarity |
NPD7037 |
Approved |
0.703 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7025 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7021 |
Intermediate Similarity |
NPD7340 |
Approved |
0.7012 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7007 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7006 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD8099 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD8252 |
Approved |
0.7 |
Intermediate Similarity |
NPD8251 |
Approved |
0.6992 |
Remote Similarity |
NPD940 |
Approved |
0.6992 |
Remote Similarity |
NPD846 |
Approved |
0.6987 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6986 |
Remote Similarity |
NPD6583 |
Phase 3 |
0.6986 |
Remote Similarity |
NPD6582 |
Phase 2 |
0.6985 |
Remote Similarity |
NPD2342 |
Discontinued |
0.6981 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6978 |
Remote Similarity |
NPD5535 |
Approved |
0.6978 |
Remote Similarity |
NPD7635 |
Approved |
0.6975 |
Remote Similarity |
NPD4675 |
Approved |
0.6975 |
Remote Similarity |
NPD4678 |
Approved |
0.6974 |
Remote Similarity |
NPD5735 |
Approved |
0.6968 |
Remote Similarity |
NPD3540 |
Phase 1 |
0.6968 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6959 |
Remote Similarity |
NPD8156 |
Discontinued |
0.6951 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.695 |
Remote Similarity |
NPD7157 |
Approved |
0.6948 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6939 |
Remote Similarity |
NPD3225 |
Approved |
0.6934 |
Remote Similarity |
NPD2684 |
Approved |
0.6933 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6932 |
Remote Similarity |
NPD4663 |
Approved |
0.6928 |
Remote Similarity |
NPD4097 |
Suspended |
0.6918 |
Remote Similarity |
NPD7041 |
Phase 2 |
0.6918 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6908 |
Remote Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.6908 |
Remote Similarity |
NPD943 |
Approved |
0.6903 |
Remote Similarity |
NPD5404 |
Approved |
0.6903 |
Remote Similarity |
NPD5405 |
Approved |
0.6903 |
Remote Similarity |
NPD5406 |
Approved |
0.6903 |
Remote Similarity |
NPD5408 |
Approved |
0.6903 |
Remote Similarity |
NPD3539 |
Phase 1 |
0.6901 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6899 |
Remote Similarity |
NPD6190 |
Approved |
0.6897 |
Remote Similarity |
NPD3496 |
Discontinued |
0.6897 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.6893 |
Remote Similarity |
NPD7906 |
Approved |
0.6892 |
Remote Similarity |
NPD2797 |
Approved |
0.6887 |
Remote Similarity |
NPD6812 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.686 |
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.6857 |
Remote Similarity |
NPD4578 |
Approved |
0.6857 |
Remote Similarity |
NPD4577 |
Approved |
0.6857 |
Remote Similarity |
NPD7843 |
Approved |
0.6855 |
Remote Similarity |
NPD5058 |
Phase 3 |
0.6849 |
Remote Similarity |
NPD1535 |
Discovery |
0.6849 |
Remote Similarity |
NPD3705 |
Approved |
0.6848 |
Remote Similarity |
NPD5929 |
Approved |
0.6839 |
Remote Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.6839 |
Remote Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.6835 |
Remote Similarity |
NPD6331 |
Phase 2 |
0.6832 |
Remote Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.6829 |
Remote Similarity |
NPD6072 |
Discontinued |
0.6828 |
Remote Similarity |
NPD4626 |
Approved |
0.681 |
Remote Similarity |
NPD4005 |
Discontinued |
0.6805 |
Remote Similarity |
NPD1247 |
Approved |
0.6803 |
Remote Similarity |
NPD1481 |
Phase 2 |
0.6803 |
Remote Similarity |
NPD1608 |
Approved |
0.68 |
Remote Similarity |
NPD8453 |
Clinical (unspecified phase) |
0.6797 |
Remote Similarity |
NPD1240 |
Approved |
0.6795 |
Remote Similarity |
NPD2796 |
Approved |
0.6792 |
Remote Similarity |
NPD2677 |
Approved |
0.679 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6788 |
Remote Similarity |
NPD6801 |
Discontinued |
0.678
|
Remote Similarity |
NPD8055 |
Clinical (unspecified phase) |